Latest News

Australian shares drop as Macquarie drags and CSL caps losses

Australian shares drop as Macquarie drags and CSL caps losses

Macquarie's lacklustre results for the quarter weighed on Australian shares, but a rally by biotech giant CSL limited the fall.

After a 0.7% gain on Wednesday, the S&P/ASX 200 lost 0.3% and closed at 8,709.40.

Financials declined 0.3%. Macquarie, which holds 3% of the benchmark index, fell 5.1%, its lowest session in three-months, after reporting a decline in net profit for the first quarter.

The resignation of the finance chief and fears over shareholder backlash regarding management pay further impacted on the mood.

Analysts at UBS said that "the overall result appears to be a little softer than expectations", noting the exposure of the top investment bank to commodities, and its reliance on asset sale had "decreased earning visibility".

CSL, which makes up 5% of Australia's index, has seen a gain of 1.5%.

The biotech company, which has significant exposure to the U.S., is on track for its best month in almost two years.

Henry Jennings is a senior analyst for the Marcus Today newsletter. He attributed these gains to investors who shifted from overvalued stocks into defensive investments.

"CSL is left behind, and it's thought that the selling was too much." Jennings stated that brokers are still optimistic about the situation and have not heard any bad news from the United States.

The day's closing price for miners was flat. Fortescue rose 4.3% following the fourth largest iron ore producer in the world reporting record shipments for its fourth quarter on lower costs. BHP, the index heavyweight, fell 0.6%.

Bapcor, the auto parts provider, said that its trading performance in the second half fell short of expectations.

The benchmark S&P/NZX 50 Index in New Zealand ended the day unchanged at 12,805.13 point. (Reporting and editing by Sumanth Nandy in Bengaluru, Nikita Jino from Bengaluru)

(source: Reuters)